Home » Science & Technology Current Affairs 2025 » Corbevax gets emergency approval for 12-18...

Corbevax gets emergency approval for 12-18 age group by DGCI

The Drugs Controller General of India (DCGI) has approved the Corona Vaccine Biologicals E Ltd's Corbevax for children in the age group of 12 to 18 years.

Sumit Arora Last updated on December 22nd, 2023 02:40 pm Leave a comment

The Drugs Controller General of India (DCGI) has approved the Corona Vaccine Biologicals E Ltd’s Corbevax for children in the age group of 12 to 18 years. Hyderabad-based pharmaceutical company Biological E Ltd said its coronavirus vaccine Corbevax, is also India’s third homegrown vaccine. Bharat Biotech’s Covaxin is being given to children aged 15 to 18 years from January 3.

About the Corbevax:

Corbevax is called a protein subunit and currently, we have an example of the hepatitis B vaccine which is also similarly a protein subunit vaccine. Corbevax and the other vaccine in India, we have Covovax from Serum Institute.

About the Author

Sumit Arora

Author

As a team lead and current affairs writer at Adda247, I am responsible for researching and producing engaging, informative content designed to assist candidates in preparing for national and state-level competitive government exams. I specialize in crafting insightful articles that keep aspirants updated on the latest trends and developments in current affairs. With a strong emphasis on educational excellence, my goal is to equip readers with the knowledge and confidence needed to excel in their exams. Through well-researched and thoughtfully written content, I strive to guide and support candidates on their journey to success.